Literature DB >> 25994165

Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay.

Nathan A Ledeboer1, Bert K Lopansri2, Neelam Dhiman3, Robert Cavagnolo3, Karen C Carroll4, Paul Granato5, Richard Thomson6, Susan M Butler-Wu7, Heather Berger7, Linoj Samuel8, Preeti Pancholi9, Lettie Swyers9, Glen T Hansen10, Nam K Tran11, Christopher R Polage11, Kenneth S Thomson12, Nancy D Hanson12, Richard Winegar13, Blake W Buchan14.   

Abstract

Bloodstream infection is a serious condition associated with significant morbidity and mortality. The outcome of these infections can be positively affected by the early implementation of effective antibiotic therapy based on the identification of the infecting organism and genetic markers associated with antibiotic resistance. In this study, we evaluated the microarray-based Verigene Gram-negative blood culture (BC-GN) assay in the identification of 8 genus or species targets and 6 genetic resistance determinants in positive blood culture broths. A total of 1,847 blood cultures containing Gram-negative organisms were tested using the BC-GN assay. This comprised 729 prospective fresh, 781 prospective or retrospective frozen, and 337 simulated cultures representing 7 types of aerobic culture media. The results were compared to those with standard bacterial culture and biochemical identification with nucleic acid sequence confirmation of the resistance determinants. Among monomicrobial cultures, the positive percent agreement (PPA) of the BC-GN assay with the reference method was as follows; Escherichia coli, 100%; Klebsiella pneumoniae, 92.9%; Klebsiella oxytoca, 95.5%; Enterobacter spp., 99.3%; Pseudomonas aeruginosa, 98.9%; Proteus spp., 100%; Acinetobacter spp., 98.4%; and Citrobacter spp., 100%. All organism identification targets demonstrated >99.5% negative percent agreement (NPA) with the reference method. Of note, 25/26 cultures containing K. pneumoniae that were reported as not detected by the BC-GN assay were subsequently identified as Klebsiella variicola. The PPA for identification of resistance determinants was as follows; blaCTX-M, 98.9%; blaKPC, 100%; blaNDM, 96.2%; blaOXA, 94.3%; blaVIM, 100%; and blaIMP, 100%. All resistance determinant targets demonstrated >99.9% NPA. Among polymicrobial specimens, the BC-GN assay correctly identified at least one organism in 95.4% of the broths and correctly identified all organisms present in 54.5% of the broths. The sample-to-result processing and automated reading of the detection microarray results enables results within 2 h of culture positivity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25994165      PMCID: PMC4508435          DOI: 10.1128/JCM.00581-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  54 in total

1.  Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Dilip Mathai; Jan M Bell; Ronald N Jones; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 2.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

3.  Rapid detection of carbapenemase-producing Pseudomonas spp.

Authors:  Laurent Dortet; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI.

Authors:  M N Al-Hasan; J E Eckel-Passow; L M Baddour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-08       Impact factor: 3.267

5.  Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions.

Authors:  Joseph T Hill; Kim-Dung T Tran; Karen L Barton; Matthew J Labreche; Susan E Sharp
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

6.  Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures.

Authors:  Nicasio Mancini; Laura Infurnari; Nadia Ghidoli; Grazia Valzano; Nicola Clementi; Roberto Burioni; Massimo Clementi
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

7.  Fatal sepsis caused by an unusual Klebsiella species that was misidentified by an automated identification system.

Authors:  Masafumi Seki; Kazuyoshi Gotoh; Shota Nakamura; Yukihiro Akeda; Tadashi Yoshii; Shinichi Miyaguchi; Hidenori Inohara; Toshihiro Horii; Kazunori Oishi; Tetsuya Iida; Kazunori Tomono
Journal:  J Med Microbiol       Date:  2013-02-28       Impact factor: 2.472

8.  Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

Authors:  David L Paterson; Wen-Chien Ko; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Robert A Bonomo; Louis B Rice; Marilyn M Wagener; Joseph G McCormack; Victor L Yu
Journal:  Clin Infect Dis       Date:  2004-06-08       Impact factor: 9.079

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients.

Authors:  David Calfee; Stephen G Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

View more
  46 in total

1.  A Stewardship Approach To Optimize Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Gram-Negative Bacteria.

Authors:  Conner Sothoron; Jason Ferreira; Nilmarie Guzman; Petra Aldridge; Yvette S McCarter; Christopher A Jankowski
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

Review 2.  Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Ritu Banerjee; Romney Humphries
Journal:  Virulence       Date:  2016-05-11       Impact factor: 5.882

3.  Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.

Authors:  Matthias Marschal; Johanna Bachmaier; Ingo Autenrieth; Philipp Oberhettinger; Matthias Willmann; Silke Peter
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

4.  Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.

Authors:  Michael J Satlin; Nina Cohen; Kevin C Ma; Zivile Gedrimaite; Rosemary Soave; Gülce Askin; Liang Chen; Barry N Kreiswirth; Thomas J Walsh; Susan K Seo
Journal:  J Infect       Date:  2016-07-09       Impact factor: 6.072

5.  Direct Screening of Blood by PCR and Pyrosequencing for a 16S rRNA Gene Target from Emergency Department and Intensive Care Unit Patients Being Evaluated for Bloodstream Infection.

Authors:  M S Moore; M G McCarroll; C D McCann; L May; N Younes; J A Jordan
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

6.  Comparison of rapid hybridization-based pathogen identification and resistance evaluation in sepsis using the Verigene® device paired with "good old culture".

Authors:  Michael Berktold; Wolfgang Mutschlechner; Dorothea Orth-Höller
Journal:  Wien Klin Wochenschr       Date:  2016-09-13       Impact factor: 1.704

7.  Benefits of Adding a Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program.

Authors:  Shawn H MacVane; Frederick S Nolte
Journal:  J Clin Microbiol       Date:  2016-08-03       Impact factor: 5.948

8.  Current state of the art in rapid diagnostics for antimicrobial resistance.

Authors:  Rathina Kumar Shanmugakani; Balaji Srinivasan; Marshall J Glesby; Lars F Westblade; Washington B Cárdenas; Tony Raj; David Erickson; Saurabh Mehta
Journal:  Lab Chip       Date:  2020-07-09       Impact factor: 6.799

Review 9.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 10.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Use with Positive Blood Cultures: Methodology, Performance, and Optimization.

Authors:  Matthew L Faron; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.